Product Recalls in Florida

Product recalls affecting Florida — including food, drugs, consumer products, medical devices, and vehicles distributed to Florida. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,873 recalls have been distributed to Florida in the last 12 months.

55,837 total recalls
2,873 in last 12 months

Showing 1082110840 of 13,925 recalls

DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Famotodine Tablets Recalled by Wockhardt Usa Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Famotodine Tablets Recalled by Wockhardt Usa Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Zonisamide Capsules Recalled by Wockhardt Usa Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Lansoprazole Delayed-Release Capsules Recalled by Wockhardt Usa Inc. Due to...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Captopril Tablets Recalled by Wockhardt Usa Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Zolpidem Tartrate Tablets Recalled by Wockhardt Usa Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Lansoprazole Delayed-Release Capsules Recalled by Wockhardt Usa Inc. Due to...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Lisinopril Tablets USP Recalled by Wockhardt Usa Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Azithromycin Tablets Recalled by Wockhardt Usa Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Lansoprazole Delayed-Release Capsules Recalled by Wockhardt Usa Inc. Due to...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Zonisamide Capsules Recalled by Wockhardt Usa Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Captopril Tablets Recalled by Wockhardt Usa Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Metoprolol Succinate Extended-Release Tablets Recalled by Wockhardt Usa Inc....

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Metoprolol Succinate Extended-Release Tablets Recalled by Wockhardt Usa Inc....

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Metoprolol Succinate Extended-Release Tablets Recalled by Wockhardt Usa Inc....

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Lisinopril Tablets USP Recalled by Wockhardt Usa Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Azithromycin Tablets Recalled by Wockhardt Usa Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Captopril Tablets Recalled by Wockhardt Usa Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Lamotrigine Extended-Release Tablets Recalled by Wockhardt Usa Inc. Due to...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2015· Wockhardt Usa Inc.

Recalled Item: Tamsulosin Hydrochloride Capsules Recalled by Wockhardt Usa Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund